Hematopoietic Stem Cell Transplantation for CNS Autoimmune Disorders for Adults and Children: Long-Term Outcomes - Experience of the Russian Federation

Conclusions. HSCT is used both for children and adults in Russia. It is successful approach for refractory MS and pediatric NMO treatment. In-time HSCT can significantly improve the outcome. Late effects can be found in these patients, so it's important to find it and give adequate rehabilitation. Thus, the risk/benefit ratio of HSCT in our population of these patients are very favorable.DisclosuresNo relevant conflicts of interest to declare.

Source: Blood - November 21, 2018 Category: Hematology Authors: Kirgizov, K., Skorobogatova, E., Fedorenko, D., Volkova, E., Polushin, A., Pristanskova, E., Blagonravova, O., Piliya, S., Bembeeva, R., Zubarovskaya, L., Zander, A., Afanasyev, B., Rumyantsev, A. Tags: 731. Clinical Autologous Transplantation: Results Source Type: research